Nurse Practitioner, Family · Indianapolis, IN
NPI
1326240607
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1633 N Capitol Ave, Suite 300
Indianapolis, IN, 46202
Phone (317) 962-3724
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,788
113 services
Medicare patients, 2024
35
Average age 59
Drug cost, 2024
$5.1M
3,269 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martha L Greenwald was code 99213 (office e&m - established), 72 times for 35 patients. In total Martha L Greenwald billed 113 services in 5 codes, and Medicare paid $2,788.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 72 | 35 | $31.46 | $2,265 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 36 | 25 | $9.24 | $333 |
By year: 2022 $3,350 for 101 services; 2023 $2,765 for 72 services; 2024 $2,788 for 113 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martha L Greenwald prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 362 prescriptions and refills. In total Martha L Greenwald wrote 3,269 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 362 | 362 | 37 | $1.5M |
| Tivicay Dolutegravir Sodium | 289 | 289 | 30 | $685K |
| Descovy Emtricitabine/Tenofov Alafenam | 182 | 182 | 18 | $409K |
| Atorvastatin Calcium Generic | 136 | 144 | 14 | $533 |
| Dovato Dolutegravir Sodium/Lamivudine | 124 | 124 | 12 | $356K |
| Valacyclovir Valacyclovir Hcl | 99 | 101 | 14 | $1,961 |
| Omeprazole Generic | 92 | 100 | 11 | $397 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 79 | 79 | Under 11 | $339K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 79 | 79 | 11 | $370K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 76 | 94 | 13 | $2,070 |
| Prezcobix Darunavir/Cobicistat | 76 | 76 | Under 11 | $181K |
| Lisinopril Generic | 60 | 82 | Under 11 | $216 |
| Montelukast Sodium Generic | 52 | 54 | Under 11 | $104 |
| Famotidine Generic | 51 | 51 | Under 11 | $309 |
| Rukobia Fostemsavir Tromethamine | 50 | 50 | Under 11 | $451K |
Brand drugs: 1,596 claims; generic drugs: 1,634 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Martha L Greenwald were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.